Patent classifications
C07C55/07
Salts of methyl 6-(2,4-dichlorophenyl)-5-[4-[(3S)-l-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylate and preparation process thereof
Herein are provided novel salts of methyl 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylate namely the oxalate salt ##STR00001##
and the dibenzoyltartrate salt ##STR00002##
Salts of methyl 6-(2,4-dichlorophenyl)-5-[4-[(3S)-l-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylate and preparation process thereof
Herein are provided novel salts of methyl 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylate namely the oxalate salt ##STR00001##
and the dibenzoyltartrate salt ##STR00002##
Facile Synthesis of Aluminum Salts Using Activated Aluminum Precursor
The present disclosure provides a method of producing an aluminum salt, comprising reacting activated aluminum metal (Al.sup.(0)) with an anion donor. Also provided are aluminum salts prepared by the disclosed methods.
Facile Synthesis of Aluminum Salts Using Activated Aluminum Precursor
The present disclosure provides a method of producing an aluminum salt, comprising reacting activated aluminum metal (Al.sup.(0)) with an anion donor. Also provided are aluminum salts prepared by the disclosed methods.
Brivaracetam intermediate, preparation method therefor, and preparation method for brivaracetam
The present invention relates to a brivaracetam intermediate, a preparation method therefor, and a preparation method for brivaracetam. The steps of the method for preparing brivaracetam described in the present invention are short and the raw materials are cheap, moreover, the method is simple and highly effective without requiring isomer separation by means of column chromatography or asymmetric synthesis, being suitable for industrial large-scale production. In addition, disclosed by the present invention is a compound as shown in formula (II), which may be used for the synthesis of brivaracetam. ##STR00001##
Brivaracetam intermediate, preparation method therefor, and preparation method for brivaracetam
The present invention relates to a brivaracetam intermediate, a preparation method therefor, and a preparation method for brivaracetam. The steps of the method for preparing brivaracetam described in the present invention are short and the raw materials are cheap, moreover, the method is simple and highly effective without requiring isomer separation by means of column chromatography or asymmetric synthesis, being suitable for industrial large-scale production. In addition, disclosed by the present invention is a compound as shown in formula (II), which may be used for the synthesis of brivaracetam. ##STR00001##
METHOD FOR PREPARING LITHIUM IRON MANGANESE PHOSPHATE PRECURSOR AND METHOD FOR PREPARING LITHIUM IRON MANGANESE PHOSPHATE
Disclosed are a method for preparing lithium iron manganese phosphate precursor and a method for preparing lithium iron manganese phosphate. The method for preparing lithium iron manganese phosphate precursor comprises the following steps: (1) preparing liquid material A and liquid material B, wherein the liquid material A is a mixed solution of manganese salt and iron salt, and the liquid material B is oxalic acid or phosphoric acid solution; (2) subjecting liquid material A and liquid material B to a co-precipitation reaction in a rotary packed bed (100) to obtain a first slurry; (3) washing and filtering the first slurry to obtain a filter cake; (4) mixing the filter cake with water, adding a carbon source, and stirring until uniform to obtain a second slurry; (5) homogenizing the second slurry; (6) drying the homogenized second slurry, to obtain the lithium iron manganese phosphate precursor. The particle size of the lithium iron manganese phosphate precursor prepared by the method is finer and more uniform than that of a precursor prepared by a traditional method using a reaction kettle, the preparation speed is increased, and the carbon coating is more uniform. FIG. 1: : lithium iron manganese phosphate precursor FIG. 2:
: lithium iron manganese phosphate FIG. 3:
(V): Voltage (V)
(mAh/g): Specific capacity (mAh/g)
: charge curve
: discharge curve FIG. 4:
(mAh/g): Discharge specific capacity (mAh/g)
METHOD FOR PREPARING LITHIUM IRON MANGANESE PHOSPHATE PRECURSOR AND METHOD FOR PREPARING LITHIUM IRON MANGANESE PHOSPHATE
Disclosed are a method for preparing lithium iron manganese phosphate precursor and a method for preparing lithium iron manganese phosphate. The method for preparing lithium iron manganese phosphate precursor comprises the following steps: (1) preparing liquid material A and liquid material B, wherein the liquid material A is a mixed solution of manganese salt and iron salt, and the liquid material B is oxalic acid or phosphoric acid solution; (2) subjecting liquid material A and liquid material B to a co-precipitation reaction in a rotary packed bed (100) to obtain a first slurry; (3) washing and filtering the first slurry to obtain a filter cake; (4) mixing the filter cake with water, adding a carbon source, and stirring until uniform to obtain a second slurry; (5) homogenizing the second slurry; (6) drying the homogenized second slurry, to obtain the lithium iron manganese phosphate precursor. The particle size of the lithium iron manganese phosphate precursor prepared by the method is finer and more uniform than that of a precursor prepared by a traditional method using a reaction kettle, the preparation speed is increased, and the carbon coating is more uniform. FIG. 1: : lithium iron manganese phosphate precursor FIG. 2:
: lithium iron manganese phosphate FIG. 3:
(V): Voltage (V)
(mAh/g): Specific capacity (mAh/g)
: charge curve
: discharge curve FIG. 4:
(mAh/g): Discharge specific capacity (mAh/g)
ISOFAGOMINE SALTS, METHODS OF USE AND FORMULATIONS
The present invention relates generally to the field of pharmaceuticals, and specifically relates to isofagomine (IFG), novel salts thereof and preparation methods and uses of these, for example, in formulating pharmaceutical compositions for the treatment of Gaucher disease. Also provided are novel crystalline forms of isofagomine salts, methods for preparing the crystalline forms, and their use in formulating pharmaceutical compositions.
SALT OF ARYLAMINOPURINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF
Provided in the present invention are a salt of an arylaminopurine derivative represented by Formula (2), a preparation method therefor and the use thereof. The salt obtained in the present invention has good crystallinity and significantly improved solubility relative to that in the free form, and the preferred salt and crystal form have low hygroscopicity and can exist stably. Therefore, compared with the free form of arylaminopurine derivatives or other salts, it is easier to prepare same into a medicine.
##STR00001##